Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > How does Accelerated Approval work

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Feb 23, 2024 2:48pm

81 Views

Post# 35896258

RE:RE:RE:RE:RE:How does Accelerated Approval work

Hello Noteable, you are posting a news release that is now almost 3 years old. The company should have been able to go ahead with the phase 3 as a result or made more progress by now as the aware 1 was specifically for the biomarkers in relation to the mbc trial.

Oncolytics Biotech® and SOLTI Achieve Primary Endpoint in AWARE-1 Study

News provided by

Oncolytics Biotech® Inc.

12 Apr, 2021, 07:02 ET

Also in regards to AA, yes I do think it is possible but not at this point as if they had already applied then most likely they would have gotten a response back by now as especially with fast track things would have been known by now.

There has not been a lot of transparancy and there are still a lot of unknowns but am still hopeful that we will know a lot more before the AGM and hopefully a deal by then also.

As for the 5 U.S. or 6.5 Canadian value you are putting on the loss provisions over the years with onc. All I can say is that I hope that you are right. but The net benefits of an acquired company's accumulated deficit is different than the actual accumulated value so I guess we shall see if and when it all happens.